Skip to main content

Table 2 Cross-tabulation of quality appraisal tools (QATs) against study designs

From: Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools

QAT (Reference)1 Animal study Before-and-after study (controlled) Before-and-after-study (uncontrolled) Case-control study Case report Case series (Cluster) rRCT Cohort study Cost-effectiveness (-benefit, -consequence) analysis Cost-utility analysis Cross-sectional study Diagnostic test accuracy study Document analysis Ecological study Focus groups (Individually) RCT Interrupted time series Interview study (Observation study) Laboratory study Non-economic modeling study nRCT Process evaluation Self-controlled case series
Van der Worp [37] X                   X     
NICE (qualitative) [48]              X   X    X     X  
CASP [36]              X   X    X     X  
SIGN (diagnostic) [42]             X            
Cho [30]   X X X X X X X    X      X      X   X
Hoy [45]            X             
Al-Jader [33]            X             
SIGN (cohort) [40]         X                
NOS [44]     X     X                X
EPOC [50]                  X       
SIGN (case-control) [41]     X                    X
NICE (intervention) [46]        X          X      X   
Cochrane [35]                 X        
SIGN (RCT) [39]                 X        
NICE (correlation) [47]               X          
Downs et al. [31]   X X X    X X         X      X   
Loney et al. [32]            X             
QHES [34]          X X           X    
EPHPP [38]   X X X    X X         X X     X   
SIGN (economic) [43]          X            X    
NICE (economic) [49]          X            X    
  1. 1Complete names of the included QATs (in the order of appearance): Van der Worp: Aspects of study quality to be reported; NICE (qualitative): Quality appraisal checklist: qualitative studies; CASP: Critical appraisal skills programme tools; SIGN (diagnostic): Scottish Intercollegiate Guidelines Network (SIGN) checklist 5 (diagnostic studies); Cho: Methodologic quality instrument; Hoy: Tool to assess risk of bias in prevalence studies; Al-Jader: Quality scoring system for epidemiological surveys of genetic disorders; SIGN (diagnostic): Scottish Intercollegiate Guidelines Network (SIGN) checklist 3 (cohort studies); NOS: Newcastle-Ottawa Scale; EPOC: Cochrane Effective Practice and Organization of Care (EPOC) Groups risk of bias tool for interrupted time series; SIGN (case-control): Scottish Intercollegiate Guidelines Network (SIGN) checklist 4 (case-control studies); NICE (intervention): National Institute for Health and Care Excellence quality appraisal checklist for quantitative intervention studies; Cochrane: Cochrane risk of bias tool for RCTs; SIGN (RCT): Scottish Intercollegiate Guidelines Network (SIGN) checklist 2 (RCTs); NICE (correlation): National Institute for Health and Care Excellence quality appraisal checklist for quantitative studies reporting correlations and associations; Downs: Checklist for the assessment of the methodological quality of randomized and non-randomized studies of health care interventions; Loney: Guidelines for critically appraising studies of prevalence or incidence of a health problem; QHES: Quality of Health economic studies instrument; EPHPP: Effective Public Health practice projects quality assessment tool for quantitative studies; SIGN (economic): Scottish Intercollegiate Guidelines Network (SIGN) checklist 6 (economic studies); NICE (economic): National Institute for Health and Care Excellence quality appraisal checklist for economic evaluations.